NDRA (ENDRA Life Sciences Inc) Wutah pendapatan triwulanan

ENDRA Life Sciences develops thermoacoustic modules for ultrasound, securing long-term revenue through licensing. The company aims to capture this niche before medtech behemoths implement similar functionalities. Growth depends on FDA approval and the validation of the TAEUS system. Quarterly revenue changes demonstrate financial stability, where the value of 0.00 reflects this status.
Rincian analitis perusahaan ENDRA Life Sciences Inc (NDRA)

To objectively evaluate the issuer, it is essential for the manager to separate market noise from actual business dynamics by measuring the percentage change in revenue for the current quarter compared to the same period last year. By analyzing quarterly sales growth, the investor determines demand stability, which is critical for ENDRA Life Sciences (NDRA) when scaling TAEUS thermoacoustic systems through strategic partnerships with ultrasound diagnostic manufacturers.